San Bruno, California
United States
50
2025-09-25
The entities that hold a legal rights for patent applications filed by inventor Naduthambi Devan:
Devan Naduthambi from San Bruno, US has applied for patents for these inventions. The list has both pending applications and granted patents:
SARS-COV2 MAIN PROTEASE INHIBITORS
#2 | 2025-09-04SARS-COV2 MAIN PROTEASE INHIBITORS
#3 | 2025-08-28PD-1/PD-L1 INHIBITORS
#4 | 2025-06-19MCL1 INHIBITORS
#5 | 2025-06-12SUBSTITUTED PYRIDOTRIAZINE COMPOUNDS AND USES THEREOF
#6 | 2025-05-15MCL-1 INHIBITORS
#7 | 2025-02-06SARS-COV2 MAIN PROTEASE INHIBITORS
#8 | 2025-01-30PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#9 | 2024-09-19PHOSPHOLIPID COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#10 | 2024-09-12Substituted pyridotriazine compounds and uses thereof
#11 | 2024-07-18SARS-COV2 MAIN PROTEASE INHIBITORS
#12 | 2024-07-114'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE
#13 | 2024-06-20ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#14 | 2024-04-11SARS-COV2 main protease inhibitors
#15 | 2024-01-25PHOSPHOLIPID COMPOUNDS AND USES THEREOF
#16 | 2023-11-30ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#17 | 2023-11-02MCL1 inhibitors
#18 | 2023-10-05MCL-1 inhibitors
#19 | 2023-09-28PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE
#20 | 2023-08-17Substituted pyridotriazine compounds and uses thereof
#21 | 2023-08-10Phospholipid compounds and uses thereof
#22 | 2023-07-06Phospholipid compounds and methods of making and using the same
#23 | 2023-07-06PD-1/PD-L1 INHIBITORS
#24 | 2022-11-17Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same
#25 | 2022-10-27MCL-1 inhibitors
#26 | 2022-08-25Substituted pyridotriazine compounds and uses thereof
#27 | 2022-04-21Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use
#28 | 2022-03-17Phospholipid compounds and uses thereof
#29 | 2021-10-21PD-1/PD-L1 INHIBITORS
#30 | 2021-06-10MCL1 inhibitors
#31 | 2021-02-25PD-1/PD-L1 inhibitors
#32 | 2021-01-28PD-1/PD-L1 inhibitors
#33 | 2020-10-22MCL-1 inhibitors
#34 | 2020-01-16PD-1/PD-L1 inhibitors
#35 | 2019-11-21MCL-1 inhibitors
#36 | 2019-11-14PD-1/PD-L1 inhibitors
#37 | 2019-09-05PD-1/PD-L1 inhibitors
#38 | 2019-01-17Tank-binding kinase inhibitor compounds
#39 | 2018-12-27Tank-binding kinase inhibitor compounds
#40 | 2018-10-25PD-1/PD-L1 INHIBITORS
#41 | 2018-03-29Phosphatidylinositol 3-kinase inhibitors
#42 | 2018-03-29Phosphatidylinositol 3-kinase inhibitors
#43 | 2018-03-08PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
#44 | 2017-06-22Tank-binding kinase inhibitor compounds
#45 | 2016-04-07Tank-binding kinase inhibitor compounds
#46 | 2016-01-28Phosphatidylinositol 3-kinase inhibitors
#47 | 2015-12-17Phosphatidylinositol 3-kinase inhibitors
#48 | 2015-12-17Phosphatidylinositol 3-kinase inhibitors
#49 | 2015-12-17Phosphatidylinositol 3-kinase inhibitors
#50 | 2015-12-03Tank-binding kinase inhibitor compounds
1375165 ⎘